LLY

1,015.54

-1.12%↓

JNJ

242.2

-1.01%↓

ABBV

224.89

-0.91%↓

NVS

165.61

-0.93%↓

MRK

119.59

-2.33%↓

LLY

1,015.54

-1.12%↓

JNJ

242.2

-1.01%↓

ABBV

224.89

-0.91%↓

NVS

165.61

-0.93%↓

MRK

119.59

-2.33%↓

LLY

1,015.54

-1.12%↓

JNJ

242.2

-1.01%↓

ABBV

224.89

-0.91%↓

NVS

165.61

-0.93%↓

MRK

119.59

-2.33%↓

LLY

1,015.54

-1.12%↓

JNJ

242.2

-1.01%↓

ABBV

224.89

-0.91%↓

NVS

165.61

-0.93%↓

MRK

119.59

-2.33%↓

LLY

1,015.54

-1.12%↓

JNJ

242.2

-1.01%↓

ABBV

224.89

-0.91%↓

NVS

165.61

-0.93%↓

MRK

119.59

-2.33%↓

Search

Progyny Inc

Open

BrancheGesundheitswesen

21.43 0.47

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

20.87

Max

21.6

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.2M

14M

Verkäufe

-20M

313M

KGV

Branchendurchschnitt

34.371

108.767

EPS

0.45

Gewinnspanne

4.425

Angestellte

675

EBITDA

-3.1M

25M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+42.69% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

26. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

253M

1.8B

Vorheriger Eröffnungskurs

20.96

Vorheriger Schlusskurs

21.43

Nachrichtenstimmung

By Acuity

59%

41%

302 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Progyny Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Feb. 2026, 23:25 UTC

Heiße Aktien

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25. Feb. 2026, 23:15 UTC

Ergebnisse

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25. Feb. 2026, 23:54 UTC

Market Talk

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25. Feb. 2026, 23:47 UTC

Ergebnisse

Ferrovial 4Q Net EUR197M >FER.MC

25. Feb. 2026, 23:45 UTC

Ergebnisse

Ferrovial 4Q Rev EUR2.72B >FER.MC

25. Feb. 2026, 23:42 UTC

Ergebnisse

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25. Feb. 2026, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Company's Business Operations Remain Normal >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY EPS CNY47.67 >TCOM

25. Feb. 2026, 23:06 UTC

Ergebnisse

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25. Feb. 2026, 23:01 UTC

Ergebnisse

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25. Feb. 2026, 23:00 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

25. Feb. 2026, 23:00 UTC

Market Talk
Ergebnisse

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25. Feb. 2026, 22:56 UTC

Market Talk
Ergebnisse

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25. Feb. 2026, 22:43 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25. Feb. 2026, 22:40 UTC

Market Talk
Ergebnisse

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25. Feb. 2026, 22:40 UTC

Ergebnisse

Karoon Energy Says Search for New CFO Well Advanced

25. Feb. 2026, 22:39 UTC

Ergebnisse

Karoon Energy Says CFO Ray Church to Leave Company

25. Feb. 2026, 22:39 UTC

Ergebnisse

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25. Feb. 2026, 22:38 UTC

Ergebnisse

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Peer-Vergleich

Kursveränderung

Progyny Inc Prognose

Kursziel

By TipRanks

42.69% Vorteil

12-Monats-Prognose

Durchschnitt 29.65 USD  42.69%

Hoch 35 USD

Tief 21.92 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Progyny Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

7 ratings

6

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

22.91 / 23.375Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

302 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat